Cite

    Yu, Z. et al. (2020). Discovery of prolyl hydroxylase 2 inhibitors with new chemical scaffolds as in vivo active erythropoietin inducers through a combined virtual screening strategy. Chemical biology & drug design. pp. 270-278. [Online].